Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Silverchair Information Systems full text link Silverchair Information Systems Free PMC article
Full text links

Actions

.2016 Nov;154(1):43-54.
doi: 10.1093/toxsci/kfw145. Epub 2016 Aug 4.

Dietary Omega-3 Polyunsaturated Fatty Acids Prevent Vascular Dysfunction and Attenuate Cytochrome P4501A1 Expression by 2,3,7,8-Tetrachlorodibenzo-P-Dioxin

Affiliations

Dietary Omega-3 Polyunsaturated Fatty Acids Prevent Vascular Dysfunction and Attenuate Cytochrome P4501A1 Expression by 2,3,7,8-Tetrachlorodibenzo-P-Dioxin

Elani F Wiest et al. Toxicol Sci.2016 Nov.

Abstract

Omega-3 polyunsaturated fatty acids (n-3 PUFAs) found in fish protect against cardiovascular morbidity and mortality; however, many individuals avoid fish consumption due to concerns about pollutants. We tested the hypothesis that n-3 PUFAs would prevent vascular dysfunction induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). C57Bl/6 male mice were fed a chow or n-3 PUFA diet for 10 weeks and were exposed to vehicle or 300 ng/kg/d TCDD during the final 2 weeks on each diet. Aortic vasoconstriction mediated by arachidonic acid (AA) ± SKF525 (P450 inhibitor) or SQ29548 (thromboxane/prostanoid [TP] receptor antagonist) was assessed. RBC fatty acids and expression of n-3 and n-6 PUFA metabolites were analyzed. Cytochrome P4501A1 (CYP1A1), CYP1B1, and aryl hydrocarbon receptor (AHR) expression was measured. TCDD significantly increased AA-mediated vasoconstriction on a chow diet by increasing the contribution of P450s and TP receptor to the constriction response. In contrast, the n-3 PUFA diet prevented the TCDD-induced increase in AA vasoconstriction and normalized the contribution of P450s and TP receptor. Although TCDD increased the levels of AA vasoconstrictors on the chow diet, this increase was prevent by the n-3 PUFA diet. Additionally, the n-3 PUFA diet significantly increased the levels of n-3 PUFA-derived vasodilators and TCDD increased these levels further. Interestingly, the n-3 PUFA diet significantly attenuated CYP1A1 induction by TCDD without a significant effect on AHR expression. These data suggest that n-3 PUFAs can prevent TCDD-induced vascular dysfunction by decreasing vasoconstrictors, increasing vasodilators, and attenuating CYP1A1 induction, which has been shown previously to contribute to TCDD-induced vascular dysfunction.

Keywords: 2,3,7,8-tetrachlorodibenzo-p-dioxin; 20-HETE; arachidonic acid; aryl hydrocarbon receptor; cytochrome P4501A1; omega-3 polyunsaturated fatty acids; vasoconstriction.

© The Author 2016. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Effects of TCDD and an n-3 PUFA diet on vasoconstriction responses to AA.A, Dose–response for AA-mediated constriction in aortic rings from control and TCDD-exposed mice fed a chow or n-3 PUFA-enriched diet.B, AUC analysis of the dose-response curves shown in panel A.C, AUC analysis of AA-mediated constriction in the presence of a P450 inhibitor (SKF525, 25 µM) or TP receptor antagonist (SQ29548, 100 nM). Data are shown as mean ± SEM, n = 6–7/group and were analyzed by 2 way, repeated measures ANOVA withpost hoc Holm-Sidak comparisons. Panels A and B: *P < .05 compared with chow control;#P < .05 compared with chow TCDD; Panel C: *P < .05 compared with AA-constriction in the absence of inhibitor.
FIG. 2
FIG. 2
Effects of TCDD and an n-3 PUFA diet on AA-, EPA-, and DHA-derived monohydroxy metabolites commonly generated by CYP4A12 determined by LC-MS/MS from liver and plasma.A,B, Hepatic and plasma concentrations of 19-HETE and 20-HETE from control and TCDD-exposed mice fed a chow or n-3 PUFA-enriched diet.C,D, Hepatic and plasma levels of 20-HEPE and 22-HDHA from control and TCDD-exposed mice fed a chow or n-3 PUFA-enriched diet. Data are shown as mean ± SEM, n = 8/group and were analyzed by 2-way ANOVA withpost hoc Holm-Sidak comparisons. *Above a horizontal line, indicates a statistically significant difference between chow and n-3 diet,P < .05. *Above a vertical bar indicates a significant difference between control and TCDD exposure groups,P < .05. 20-HEPE, 20-hydroxyeicosapentaenoic acid; 19- and 20-HETE, 19- and 20-hydroxyeicosatrienoic acid; 22-HDHA, 22-hydroxydocosahexaenoic acid.
FIG. 3
FIG. 3
Vasoconstriction effects of 20-HETE in the absence or presence of TP receptor antagonist.A, Representative tracing of 20-HETE (10−5.4 M) constriction of mouse aortic ring ± TP receptor antagonist (SQ29548, 100 nM).B, AUC analysis of 20-HETE constriction ± TP receptor antagonist (SQ29548). Data are shown as mean ± SEM, n = 3/group and were analyzed byt-test. ***P < .0001. 20-HETE, 20-hydroxyeicosatrienoic acid.
FIG. 4
FIG. 4
Effects of TCDD and an n-3 PUFA diet on mRNA expression of Cyp4a12 and prostaglandin endoperoxide synthase 2 (aka cyclooxygenase 2).A, Cyp4a12 mRNA expression in liver and kidney, normalized to the housekeeping gene, RNA polymerase 2 (Pol2).B, Cyclooxygenase 2 mRNA expression in lung, normalized to Pol2. Data are shown as mean ± SEM, n = 6-8/group and were analyzed by 2-way ANOVA withpost hoc Holm-Sidak comparisons. *Above a horizontal line, indicates a statistically significant difference between chow and n-3 diet,P < .05. *Above a vertical bar indicates a significant difference between control and TCDD exposure groups, *P < .05, ***P < .001.
FIG. 5
FIG. 5
Effects of TCDD and an n-3 PUFA diet on the profile of AA-, EPA-, and DHA-derived monoepoxide metabolites determined by LC-MS/MS from liver and plasma.A,B, AA-derived EETs;C,D, EPA-derived EEQs; andE,F, DHA-derived EDPs.G,H, Sum (Σ) of EETs, EEQ, and EDPs from liver and plasma. Data were analyzed by 2-way ANOVA withpost hoc Holm-Sidak comparisons. *Above a horizontal line, indicates a statistically significant difference between chow and n-3 diet,P < .05. *Above a vertical bar indicates a significant difference between control and TCDD exposure groups, * P < .05. EET, epoxyeicosatrienoic acid; EEQ, epoxyeicosatetraenoic acid; EDP, epoxydocosapentaenoic acid.
FIG. 6
FIG. 6
Effects of TCDD and an n-3 PUFA diet on mRNA expression of Cyp1a1 and Cyp1b1.A–E, mRNA expression of Cyp1a1 and Cyp1b1, normalized to normalized to the housekeeping gene, RNA polymerase 2 (Pol2), in liver, kidney, aorta, heart, and lung. Data were analyzed by 2-way ANOVA withpost hoc Holm-Sidak comparisons. *Above a horizontal line, indicates a statistically significant difference between chow and n-3 diet,P < .05. *Above a vertical bar indicates a significant difference between control and TCDD treatment groups within the same diet, ** P < .01, *** P < .001.#Above a vertical bar indicates difference between chow and n-3 PUFA diets within the same treatment group,#P < .05,##P < .01,###P < .001.
FIG. 7
FIG. 7
Effects of TCDD and an n-3 PUFA diet on protein expression of CYP1A1.A,B, Representative western blot of CYPOR and CYP1A1 protein, and quantification of CYP1A1 protein expression, normalized to CYPOR expression, in lung and heart microsomes, respectively. Data were analyzed by 2-way ANOVA withpost hoc Holm-Sidak comparisons. *P < .05, ***P < .001 versus control within the same diet;##P < .01 versus TCDD treatment on chow diet.
See this image and copyright information in PMC

References

    1. Agbor L. N., Wiest E. F., Rothe M., Schunck W. H., Walker M. K. (2014). Role of CYP1A1 in modulating the vascular and blood pressure benefits of omega-3 polyunsaturated fatty acids. J. Pharmacol. Exp. Ther. 351, 688–698. - PMC - PubMed
    1. Arnold C., Konkel A., Fischer R., Schunck W. H. (2010a). Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids. Pharmacol. Rep. 62, 536–547. - PubMed
    1. Arnold C., Markovic M., Blossey K., Wallukat G., Fischer R., Dechend R., Konkel A., von Schacky C., Luft F. C., Muller D. N., et al. (2010b). Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids. J Biol Chem 285, 32720–32733. - PMC - PubMed
    1. Bui P., Solaimani P., Wu X., Hankinson O. (2012). 2,3,7,8-Tetrachlorodibenzo-p-dioxin treatment alters eicosanoid levels in several organs of the mouse in an aryl hydrocarbon receptor-dependent fashion. Toxicol. Appl. Pharmacol. 259, 143–151. - PMC - PubMed
    1. Choudhary D., Jansson I., Stoilov I., Sarfarazi M., Schenkman J. B. (2004). Metabolism of retinoids and arachidonic acid by human and mouse cytochrome p450 1b1. Drug Metab. Dispos. 32, 840–847. - PubMed

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full text links
Silverchair Information Systems full text link Silverchair Information Systems Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp